Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 78213-16-8
2. Diclofenac (diethylamine)
3. Diclofenac Diethylammonium Salt
4. 6tgq35z71k
5. 2-[2-(2,6-dichloroanilino)phenyl]acetic Acid;n-ethylethanamine
6. Voltarol
7. Mfcd01862249
8. Benzeneacetic Acid, 2-((2,6-dichlorophenyl)amino)-, Compd. With N-ethylethanamine (1:1)
9. Diclofenac Diethylammonium
10. Diclofenac Diethylamine Salt
11. Unii-6tgq35z71k
12. Voltaren Emulgel (tn)
13. N-ethylethanaminium{2-[(2,6-dichlorophenyl)amino]phenyl}acetate
14. Diethylammonium Diclofenac
15. 2-((2,6-dichlorophenyl)amino)benzeneacetic Acid, Compd. With N-ethylethanamine
16. Schembl1116300
17. Dtxsid40999449
18. 4-bromo-4-methoxybiphenyl
19. Hms3651l18
20. Hms3885e07
21. Bcp24521
22. Hy-15036a
23. S3063
24. Akos015907253
25. Ccg-268279
26. Diclofenac Diethylamine [mart.]
27. Ks-5039
28. Diclofenac Diethylamine [who-dd]
29. Sy110689
30. Db-056293
31. Diclofenac Diethylammonium Salt [mi]
32. Ft-0603077
33. Sw219367-1
34. D07817
35. H10150
36. 213d168
37. A923342
38. Diclofenac Diethylamine (diethylammonium Diclofenac)
39. Q27265501
40. Diethylamine 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
41. [2-(2,6-dichloroanilino)phenyl]acetic Acid--n-ethylethanamine (1/1)
| Molecular Weight | 369.3 g/mol |
|---|---|
| Molecular Formula | C18H22Cl2N2O2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 368.1058333 g/mol |
| Monoisotopic Mass | 368.1058333 g/mol |
| Topological Polar Surface Area | 61.4 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 315 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ANALYTICAL
ABOUT THIS PAGE
99
PharmaCompass offers a list of Diclofenac Diethylamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diclofenac Diethylamine manufacturer or Diclofenac Diethylamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diclofenac Diethylamine manufacturer or Diclofenac Diethylamine supplier.
PharmaCompass also assists you with knowing the Diclofenac Diethylamine API Price utilized in the formulation of products. Diclofenac Diethylamine API Price is not always fixed or binding as the Diclofenac Diethylamine Price is obtained through a variety of data sources. The Diclofenac Diethylamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diclofenac diethylammonium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diclofenac diethylammonium salt, including repackagers and relabelers. The FDA regulates Diclofenac diethylammonium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diclofenac diethylammonium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diclofenac diethylammonium salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diclofenac diethylammonium salt supplier is an individual or a company that provides Diclofenac diethylammonium salt active pharmaceutical ingredient (API) or Diclofenac diethylammonium salt finished formulations upon request. The Diclofenac diethylammonium salt suppliers may include Diclofenac diethylammonium salt API manufacturers, exporters, distributors and traders.
click here to find a list of Diclofenac diethylammonium salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diclofenac diethylammonium salt Drug Master File in Korea (Diclofenac diethylammonium salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diclofenac diethylammonium salt. The MFDS reviews the Diclofenac diethylammonium salt KDMF as part of the drug registration process and uses the information provided in the Diclofenac diethylammonium salt KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diclofenac diethylammonium salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diclofenac diethylammonium salt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diclofenac diethylammonium salt suppliers with KDMF on PharmaCompass.
A Diclofenac diethylammonium salt written confirmation (Diclofenac diethylammonium salt WC) is an official document issued by a regulatory agency to a Diclofenac diethylammonium salt manufacturer, verifying that the manufacturing facility of a Diclofenac diethylammonium salt active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diclofenac diethylammonium salt APIs or Diclofenac diethylammonium salt finished pharmaceutical products to another nation, regulatory agencies frequently require a Diclofenac diethylammonium salt WC (written confirmation) as part of the regulatory process.
click here to find a list of Diclofenac diethylammonium salt suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diclofenac diethylammonium salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diclofenac diethylammonium salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diclofenac diethylammonium salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diclofenac diethylammonium salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diclofenac diethylammonium salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diclofenac diethylammonium salt suppliers with NDC on PharmaCompass.
Diclofenac diethylammonium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diclofenac diethylammonium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diclofenac diethylammonium salt GMP manufacturer or Diclofenac diethylammonium salt GMP API supplier for your needs.
A Diclofenac diethylammonium salt CoA (Certificate of Analysis) is a formal document that attests to Diclofenac diethylammonium salt's compliance with Diclofenac diethylammonium salt specifications and serves as a tool for batch-level quality control.
Diclofenac diethylammonium salt CoA mostly includes findings from lab analyses of a specific batch. For each Diclofenac diethylammonium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diclofenac diethylammonium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Diclofenac diethylammonium salt EP), Diclofenac diethylammonium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diclofenac diethylammonium salt USP).
